Overall Survival in Elderly Metastatic Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade

被引:0
|
作者
Simoes, M. F. [1 ]
Medeiros, M. F. [1 ]
Maciel Santana, D. [1 ]
De Andrade Souza, C. I. [1 ]
Mendes Gomes, L. B. [1 ]
De Freitas, H. [1 ]
Petrocchi Corassa, M. [1 ]
Spina Donadio, M. D. [1 ]
De Lima, V. C. [1 ]
机构
[1] AC Camargo Canc Ctr, Clin Oncol, Antonio Prudente, Brazil
关键词
Immunotherapy; Metastatic non-small cell lung cancer; Elderly;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P09.09
引用
收藏
页码:S290 / S290
页数:1
相关论文
共 50 条
  • [41] Restricted mean survival time in advanced non-small cell lung cancer treated with immune checkpoint inhibitors
    Di Spazio, L.
    Cancanelli, L.
    Rivano, M.
    Chiumente, M.
    Mengato, D.
    Messori, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (04) : 1881 - 1889
  • [42] TREATMENT INTERRUPTIONS FOR IMMUNE RELATED ADVERSE EVENTS AND OVERALL SURVIVAL IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH FIRST LINE IMMUNE CHECKPOINT INHIBITORS (ICI)
    Goodyear, Evelyn
    Zhao, Songzhu
    Li, Mingjia
    Guo, Yihzen
    Lopez, Gabrielle
    Secor, Austin
    Das, Parthib
    Surya, Nitya
    Husain, Marium
    Grogan, Madison
    Spakowicz, Daniel
    Wei, Lai
    He, Kai
    Bertino, Erin
    Alahmadi, Asrar
    Memmott, Regan
    Kaufman, Jacob
    Presley, Carolyn
    Shields, Peter
    Carbone, David
    Otterson, Gregory
    Owen, Dwight
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1295 - A1296
  • [43] A 9-Gene Inflammation Signature Predicts Survival and Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
    Al-Bzour, N. N.
    Al-Bzour, A. N.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S176 - S177
  • [44] Hyperprogressive Disease in Advanced Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
    Lo Russo, G.
    Signorelli, D.
    Proto, C.
    Galli, G.
    Prelaj, A.
    Ferrara, R.
    Sommariva, M.
    Moro, M.
    Cancila, V.
    Ganzinelli, M.
    Brich, S.
    Sangaletti, S.
    Pruneri, G.
    Tripodo, C.
    Colombo, M. P.
    Rivoltini, L.
    Balsari, A.
    Sozzi, G.
    Boeri, M.
    Garassino, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S245 - S245
  • [45] Patterns of Failure in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Chai, Rong
    Yin, Yipengchen
    Cai, Xuwei
    Fu, Xiaolong
    Zhang, Qin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] Hyperprogressive disease in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
    Ayala de Miguel, P.
    Lopez Gallego, J.
    Gorospe Garcia, I.
    Illan Varella, A.
    Rivera Vargas, P. R.
    Posada Restrepo, A.
    Borrega Garcia, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [47] Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade
    Harel, Michal
    Lahav, Coren
    Jacob, Eyal
    Dahan, Nili
    Sela, Itamar
    Elon, Yehonatan
    Shoval, Shani Raveh
    Yahalom, Galit
    Kamer, Iris
    Zer, Alona
    Sharon, Ofer
    Carbone, David P.
    Dicker, Adam P.
    Bar, Jair
    Shaked, Yuval
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (06)
  • [48] PREDICTIVE SOLUBLE BIOMARKERS OF IMMUNE RESPONSE TO CHECKPOINT BLOCKADE IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Raza, Afsheen
    Mohsen, Reyad
    Kanbour, Aladdin
    Gul, Abdul Rehman Zar
    Philip, Anite
    Vijayakumar, Suma
    Hydrose, Shereena
    Merhi, Maysaloun
    Inchakalody, Varghese
    Uddin, Shahab
    Al Homsi, Mohammed Ussama
    Dermime, Said
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A19 - A19
  • [49] Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer
    Anagnostou, Valsamo
    Smith, Kellie N.
    Forde, Patrick M.
    Niknafs, Noushin
    Bhattacharya, Rohit
    White, James
    Adleff, Vilmos
    Phallen, Jillian
    Wali, Neha
    Hruban, Carolyn
    Guthrie, Violeta B.
    Rodgers, Kristen
    Naidoo, Jarushka
    Kang, Hyunseok
    Sharfman, William
    Georgiades, Christos
    Verde, Franco
    Illei, Peter
    Li, Qing Ka
    Gabrielson, Edward
    Brock, Malcolm
    Zahnow, Cynthia
    Baylin, Stephen B.
    Scharpf, Rob
    Brahmer, Julie R.
    Karchin, Rachel
    Pardoll, Drew M.
    Velculescu, Victor E.
    CANCER RESEARCH, 2017, 77
  • [50] Hyperprogressive Disease upon Immune Checkpoint Blockade: Focus on Non-small Cell Lung Cancer
    Lo Russo, Giuseppe
    Facchinetti, Francesco
    Tiseo, Marcello
    Garassino, Marina Chiara
    Ferrara, Roberto
    CURRENT ONCOLOGY REPORTS, 2020, 22 (05)